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Objective: The aim of the study was to evaluate the ocular tolerance and efficacy of 
double filling with perfluoro-n-octane (n-C8F18) (PFO) and polydimethyloxane (PDMS) as 
a   temporary vitreous substitute in patients with retinal detachment complicated by proliferative 
  vitreoretinopathy (PVR).
Material and methods: Tamponade was performed in 30 eyes of 30 patients by double fill-
ing with 30% PFO and 70% PDMS for an average of 23 (standard deviation 2.2) days. The 
follow-up visits were scheduled 1 week, 1 month, and 3 months after surgery. The main outcome 
measures were visual acuity, intraocular pressure (IOP), PVR reproliferation, and electrophysi-
ological parameters.
Results: The primary success rate was 80% (24/30). Fourteen patients (46.7%) had a 
  postoperative improvement in visual acuity, 12 patients (40.0%) maintained their preoperative 
visual acuity, and four patients (13.3%) experienced a reduction in visual acuity. The mean 
postoperative IOP was 19.7 mm Hg (11–32 mm Hg); nine cases (30.0%) developed an IOP 
increase that was treated with topical drops and/or systemic carbonic anhydrase inhibitors. The 
electroretinogram (ERG) and the bright flash electroretinogram (bf ERG) parameters showed a 
statistically significant difference of means between 4- and 8-week follow-up visits.
Conclusion: Our experience with double filling in selected cases of retinal detachment has 
been positive. No electroretinographic signs of retinal toxicity and a low incidence of PVR 
reproliferation were observed.
Keywords: double filling, proliferative vitreo-retinopathy, perfluoro-n-octane,   polydimethyloxane, 
retinal detachment, retinal detachment electrophysiology
Introduction
Double filling endotamponade with silicone oil and perfluorocarbon liquids can be 
used as short-term intraocular tamponade after pars plana vitrectomy (PPV) for the 
treatment of complicated rhegmatogenous retinal detachment (RRD).1
The presence of perfluorocarbon liquids reduces empty space in the inferior retina, 
where the concentration of serum components and the migrated pigmented retinal 
epithelium (RPE) cells are localized in the presence of “light tamponades” (gas or 
oil), thereby minimizing the risk of developing proliferative vitreoretinopathy (PVR) 
in the lower retina.1,2
The retinal tolerance of perfluorocarbon liquids is still controversial because their 
highly specific gravity or excitotoxicity due to aqueous exclusion can potentially cause 
mechanical damage to the retina when used as a short-term vitreous substitute.3 We 





Ulm, Germany) and polydimethyloxane (PDMS) 30% (RS 
OIL 1000 centistokes, AL.CHI.MI.A. srl) as a short-term 
intraocular tamponade after PPV for the treatment of com-
plicated RRD. PFO was chosen due to its purity, its chemical 
and physical inertness, and its lack of toxicity.4 Safe ocular 
use of PFO has already been described.5 Only 30% ocular 
volume was filled in order to avoid the formation of meniscus 
in the macular area and to minimize the weight of the PFO 
bubble on the retina.
The aim of the present study was to evaluate the ocular 
tolerance and efficacy of this double filling on human eyes. 
The main outcome measures were electrophysiological 
parameters, visual acuity, intraocular pressure (IOP), and 
PVR incidence after removal of tamponade.
Material and methods
Approval for this study was obtained from the central 
office of the Research and Ethics Committee of the hospital 
according to the tenets of the Declaration of Helsinki. Fully 
informed consent was obtained before surgery in all cases.
This study was a prospective, interventional case series 
of 30 eyes of 30 patients (15 males and 15 females) affected 
by complicated retinal detachment with PVR (D1–D2)6 who 
underwent PPV with an endotamponade of 30% PFO and 
70% PDMS.
In all patients, a best-corrected Snellen visual acuity 
(BCVA) converted into logarithm of the minimum angle of 
resolution (logMAR), IOP, anterior segment evaluation with 
slit lamp, and fundus oculi examination were performed. The 
same surgeon operated on all the patients.
The follow-up visits were scheduled 1 week, 1 month, 
and 3 months after surgery. We also performed electroretino-
graphic evaluations (electroretinogram [ERG] and bright flash 
electroretinogram [bf ERG]) in 20 of the 30 eyes 2 weeks and 
8 weeks after removal of the double fill tamponade.
surgical technique
After conjunctival peritomy, a standard three-port PPV with 
a 20-gauge system was performed. Posterior vitreous detach-
ment was induced when not already present, using aspiration 
with the vitrectomy handpiece, and the posterior hyaloid was 
removed. The vitreous cavity was expanded with injection of 
the perfluorocarbon liquid (PFCL) perfluorodecalin (HPF10, 
AL.CHI.MI.A. srl, Ponte S.Nicolò, Italy) over the posterior 
pole to obtain retinal flattening. The vitreous base was care-
fully shaved over 360° and all the membranes were dissected. 
Epiretinal membrane peeling was performed in all cases, 
whereas peripheral retinectomies were performed in 21 out 
of 30 cases in order to mobilize the retina and relieve the 
traction. Argon laser endophotocoagulation was performed 
with a 20-gauge illuminated probe in order to obtain a bar-
rage around the retinal breaks and rhegmatogenous retinal 
degenerations. PFCL was then removed and the vitreous 
cavity was expanded with air. At this time, PFO 30% and 
PDMS 70% were injected one after the other under air infu-
sion. The 30%–70% filling was estimated intraoperatively 
and was not preoperatively calculated. No scleral buckle was 
used in those cases.
After an average of 23.4 (standard deviation [SD] 2.2) 
days (range 19–27 days), the double fill tamponade was 
removed and the cataract surgery was performed at the same 
time in 17/22 phakic patients.
electroretinographic examination
ERGs were recorded using standard electrophysiological 
methods. Pupils were dilated with tropicamide 1% drops 
30 minutes before recording. The electrical activity of the ret-
ina was evoked with a stroboscopic full-field illumination.
Electrofunctional evaluations were carried out with the 
following technique. After corneal anesthesia with benoxi-
nate drops, the ERG-Jet contact electrode was positioned 
in the eye that previously underwent vitreoretinal surgery. 
The ground electrode was a skin silver chloride fixed at the 
front. The ERG was recorded using International Society 
for Clinical Electrophysiology of Vision methodology with 
white flashes at a frequency of 0.5 Hertz.7 White flashes of 
1.7 Cd/sm/sec were applied every 5 seconds in the Gauzfeld 
dome after photopic adaptation. Five readings amplified 
2000 times and with a 0.1–500 Hz frequency band were 
averaged with a signal analyzer.
The bf ERG evaluation was carried out using the above 
methodology at 53.8 cd/sm/sec after 20 minutes of dark 
adaptation (ie, scotopic adaptation).
Statistical comparisons (Systat statistical packages, 
Evanston, IL, USA) were made using Spearman’s rank cor-
relation (iris fluorescein angiography stage) and paired t-test. 




A total of 30 eyes in 30 patients (15/15 male/female) underwent 
vitrectomy with double filling (with 70% PDMS and 30% PFO) 
over a 12-month period in a single institution. The descriptive 
statistics for the patients’ preoperative status are summarized 
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Table 1 Demographics data of patients




Lens Other High myopia
g/A 24 M 3,0 16 Clear Posterior break x
s/M 83 M 3,0 14 Cortical opacities Post-traumatic RD
T/T 30 M 2,0 4 Pseudophakia Posterior break x
CM/D 77 F 2,0 13 initial nuclear sclerosis Post-traumatic RD
g/B 67 F 3,0 16 Pseudophakia Posterior break
A/P 50 F 1,0 17 nuclear sclerosis Post-traumatic RD
V/V 57 F 2,0 14 nuclear sclerosis Posterior break x
F/T 59 M 3,0 12 Pseudophakia
T/F 25 F 3,0 18 Clear Posterior break x
e/g 82 M 2,0 15 Post-traumatic lens 
dislocation
Post-traumatic RD
L/L 72 M 3,0 14 Clear Post-traumatic RD
g/M 65 M 3,0 4 Cortical opacities
A/B 42 M 2,0 13 Pseudophakia Posterior break x
g/C 60 M 2,0 16 Clear
g/P 47 M 3,0 17 Pseudophakia Post-traumatic RD
g/V 43 M 3,0 18 nuclear sclerosis Posterior break x
s/P 64 M 1,0 18 nuclear sclerosis Post-traumatic RD
D/B 70 M 3,0 14 Pseudophakia Post-traumatic RD
C/A 41 M 3,0 12 Clear Posterior break x
n/C 37 M 3,0 10 initial nuclear sclerosis Posterior break x
B/T 67 F 3,0 18 Clear Posterior break
s/e 49 F 2,0 10 Clear Post-traumatic RD
g/P 57 F 3,0 23 Pseudophakia Post-traumatic RD
A/A 50 F 3,0 17 Clear
L/M 70 F 1,0 17 nuclear sclerosis Post-traumatic RD
g/V 37 F 2,0 16 nuclear sclerosis Posterior break x
n/s 24 F 3,0 15 Clear x
g/s 83 F 3,0 16 Pseudophakia
M/D 55 F 3,0 18 Clear Post-traumatic RD
F/F 52 F 2,0 15 nuclear sclerosis Posterior break
Abbreviations: iOP, intraocular pressure; rD, retinal detachment.
The median visual acuity was 2.50 logMar and the median 
preoperative IOP was 14.7 mm Hg (range 4–23 mm Hg). Eight 
patients were pseudophakic (26.7%) and 11 patients had mild 
lens opacity (36.7%). One patient had a post-traumatic disloca-
tion of the lens (3.3%) and therefore underwent phacoemul-
sification with intraocular lens implantation at the time of 
vitrectomy. A total of 12 patients had a posterior break (40.0%) 
and 10 subjects had high myopia (33.3%). Twelve patients had 
post-traumatic retinal detachment (40.0%).
Before removal of double fill tamponade
The mean IOP was 21.7 mm Hg (range 10–40 mm Hg). 
In 16 cases, IOP increased and was treated with topical or 
systemic therapy (53.3%). In two patients, we observed 
small droplet emulsification in the inferior chamber or on the 
surface of the double filling bubble in the vitreous chamber 
(6.7%). Eleven patients (36.7%) developed cataract. These 
complications are reported in Table 2.
After removal of double fill tamponade
Double filling was exchanged with balanced salt solution 
(BSS) in 20 eyes (67%), with PDMS in six eyes (20%), 
and with air in four eyes (13%). The primary success rate, 
without further procedures, was 80% (24 out of 30). Six 
cases developed epiretinal membrane (20.0%) in the superior 
retinal quadrants. These eyes underwent peeling of epiretinal 
membranes at the time of double filling removal, after which 
time a tamponade of 1000 cSt silicon oil was added.
Functional outcome
Two months after removal of the tamponade double filling 
(Table 3), the mean visual acuity was 1.94 LogMar (P = 0.41 
t-test). Fourteen of 30 patients had an improvement in visual 
acuity postoperatively (46.7%), 12/30 patients maintained 
their preoperative visual acuity (40.0%), and 4/30 patients 
experienced a reduction in visual acuity (13.3%). The 





Table 2 Pre-double filling removal data
Patient Age Gender Preoperative 
IOP
Lens Double filling 
removal (days)




g/A 24 M 18 Clear 19 x x
s/M 83 M 19 Cortical opacities 27 x x
T/T 30 M 10 Pseudophakia 23
CM/D 77 F 15 initial nuclear
sclerosis
24 x x x
g/B 67 F 18 Pseudophakia 20
A/P 50 F 27 nuclear sclerosis 26 x x x
V/V 57 F 20 nuclear sclerosis 23 x x
F/T 59 M 32 Pseudophakia 21
T/F 25 F 40 Clear 25 x
e/g 82 M 17 Post-traumatic lens
dislocation
26 x
L/L 72 M 29 Clear 23 x x
g/M 65 M 11 Cortical opacities 23 x
A/B 42 M 25 Pseudophakia 21 x
g/C 60 M 25 Clear 26
g/P 47 M 24 Pseudophakia 27 x x
g/V 43 M 28 nuclear sclerosis 23 x
s/P 64 M 24 nuclear sclerosis 22 x x x
D/B 70 M 14 Pseudophakia 25
C/A 41 M 30 Clear 21 x x
n/C 37 M 27 initial nuclear
sclerosis
23 x x
B/T 67 F 18 Clear 27
s/e 49 F 10 Clear 23
g/P 57 F 32 Pseudophakia 24 x
A/A 50 F 17 Clear 22
L/M 70 F 17 nuclear sclerosis 23 x
g/V 37 F 16 nuclear sclerosis 23 x
n/s 24 F 25 Clear 25 x
g/s 83 F 18 Pseudophakia 21
M/D 55 F 15 Clear 20 x
F/F 52 F 30 nuclear sclerosis 26 x x
Abbreviations: iOP, intraocular pressure; PVr, proliferative vitreoretinopathy.
Hg) (range 11–32 mm Hg); nine cases developed an 
increase in IOP that was treated with topical drops and/or 
systemic   carbonic anhydrase inhibitors (30.0%). In three 
cases (10.0%), cystoid macular edema confirmed by ocular 
  coherence tomography was observed.
electrophysiological outcome
Electrofunctional evaluations (ERG and bf ERG) were car-
ried out in the 20/30 eyes (67%) in which the double tam-
ponade was substituted for BSS (Tables 4, 5 and 6).
Mean ERG amplitudes 2 and 8 weeks after removal of the 
tamponade were 55.6 (SD 24.7) and 61.6 (SD 26.0), respec-
tively. Mean amplitudes of bf ERG 2 and 8 weeks after removal 
of double filling were 107.2 (SD 49.7) and 128.9 (SD 65.8), 
respectively. With both techniques, the difference of means 
was statistically significant (Tables 4, 5 and 6).
Discussion
PVR can be defined as the growth and contraction of cellular 
membranes within the vitreous cavity and both retinal sur-
faces after RRD. This process, a frequent cause of failure after 
surgical therapy for RRD, may result in recurrent detachment 
by reopening otherwise successfully treated retinal breaks or 
creating new retinal breaks.8 PVR is a dynamic biologic phe-
nomenon with no currently available effective pharmacologic 
therapy.9 Vitreal substitutes used as stabilizing   substances 
that close the communication between the pre- and subretinal 
space minimize this proliferative phenomenon. PDMS is the 
first-choice vitreous substitute currently used for the treat-
ment of retinal detachment complicated by PVR, multiple 
retinal tears, or giant retinal tears.
Chemically, silicone oil is generated by polymerization 
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Table 4 electroretinogram evaluation data at 2 weeks and 8 weeks after surgery
ERG B bfERG B
Patient 1st exam 2nd exam Absolute delta Patient 1st exam 2nd exam Absolute delta
g/A 65,8 62,9 -2,9 g/A 142,9 115,4 -27,5
s/M 76,9 59,8 -17,1 s/M 160,5 200,5 40
L/M 90,9 88,7 -2,2 L/M 157,1 138,2 -18,9
CM/D 10,4 17,3 6,9 CM/D 36,2 46,1 9,9
g/B 53,9 80,2 26,3 g/B 156,2 162,7 6,5
A/P 83,1 96,1 13 A/P 135,4 191,9 56,5
V/V 57 55,4 -1,6 V/V 98,6 127,8 29,2
T/F 56,4 73,1 16,7 T/F 109,6 213,9 104,3
L/L 43,8 53,7 9,9 L/L 76,9 107,2 30,3
g/M 19,8 13,9 -5,9 g/M 14,2 8,3 -5,9
g/C 64,2 77,9 13,7 g/C 43,1 18,8 -24,3
g/V 75,1 71,8 -3,3 g/V 120,9 161,1 40,2
n/C 88,5 90 1,5 n/C 147,9 119,2 -28,7
C/A 12,2 24,6 12,4 C/A 57,8 77,9 20,1
A/A 52,4 68,9 16,5 A/A 179,4 186,1 6,7
n/s 82,8 95,7 12,9 n/s 151,8 188,5 36,7
M/D 56 55,2 -0,8 M/D 114,6 142,5 27,9
F/F 58,6 75,2 16,6 F/F 125,2 219,7 94,5
s/e 44,4 54,3 9,9 s/e 87,1 131,6 44,5
D/B 20,4 16,7 -3,7 D/B 29 21,1 -7,9
Table 3 Postoperative data (3 months)





CME IOP increase 
(medical therapy)
PVR
g/A 24 M 1,3 18
s/M 83 M 3,0 16
T/T 30 M 3,0 11 x
CM/D 77 F 3,0 27 x
g/B 67 F 2,0 19
A/P 50 F 1,0 18
V/V 57 F 1,3 20 x
F/T 59 M 3,0 16
T/F 25 F 1,0 32 x
e/g 82 M 2,0 18
L/L 72 M 3,0 16 x
g/M 65 M 3,0 11 x
A/B 42 M 3,0 27 x
g/C 60 M 0,7 18
g/P 47 M 2,0 19 x
g/V 43 M 1,0 18
s/P 64 M 1,0 20 x
D/B 70 M 3,0 16
C/A 41 M 1,0 32 x
n/C 37 M 2,0 18
B/T 67 F 3,0 16 x
s/e 49 F 3,0 27 x
g/P 57 F 0,7 18
A/A 50 F 2,0 19
L/M 70 F 1,0 18
g/V 37 F 1,0 20 x
n/s 24 F 1,3 16
g/s 83 F 3,0 16 x
M/D 55 F 1,0 32 x
F/F 52 F 2,0 18





siloxane and constituted of polymer chains of different 
length. It is an optically clear hydrophobic and lipophilic 
fluid with different viscosity (1000–5700 cSt) and is slightly 
lighter than water (specific gravity 0.97 g/cm3). It is perme-
able to oxygen, does not mix with water, and has a high 
surface tension toward water (35 mN/m).10
PFCLs consist of a hydrocarbon molecule in which 
hydrogen atoms are replaced by fluorine atoms. PFO is a 
saturated PFCL with highly stable carbon–fluorine bonds 
that make it virtually inert. It has a highly specific gravity 
(1.70 g/cm3), low viscosity (0.8 cSt), and an interface tension 
toward water 55 mNm.11
Both silicon oil and PFCL are hydrophobic, and surface 
energy is lowest when the two liquids are in contact. The 
two liquids prefer to be in contact and exclude aqueous 
from the interface that is displaced laterally. The double 
bubble effectively gives good contact only to the inferior 
retina, whereas the tamponade effect in the superior retina 
is less effective.
Inferior compartmentalization is an important cause of 
PVR development. In order to reduce this phenomenon and fill 
the inferior part of the retina at the same time, other kinds of 
tamponades have been tested, such as heavy silicone oils, dou-
ble filling with PDMS, fluorosilicone, semifluorinated alkanes, 
heavy silicone oils, and perfluorocarbon liquids.1,12,13
Perfluorocarbon liquids are currently used as intraopera-
tive tools in the management of retinal detachment due to 
their ability to displace subretinal fluid and to stabilize the 
retina during surgical procedures.
In order to avoid potential retinal damage caused by their 
highly specific gravity (1.94–1.76 g/cm3) and low viscos-
ity (2.7–0.8 cSt),14 the perfluorocarbon liquids are usually 
exchanged with silicone oil before the end of the procedure. 
Their retinal tolerance is still controversial, and studies evalu-
ating prolonged tamponade with these liquids are discordant. 
Some studies in rabbit eyes demonstrated retinal damage to 
photoreceptors and retinal pigment epithelium with areas of 
atrophy and necrosis, mainly of mechanical origin.15–18 Other 
histologic and electroretinographic studies performed on 
rabbit and pig eyes demonstrated their tolerance and safety 
profile.19–21
We investigated the ocular tolerance and efficacy of a 
double filling left in place in the vitreous chamber for an 
average of 3 weeks in order to allow the formation of a cho-
rioretinal scar. When proliferation of immature membranes 
occurred, they were peeled at the same time as the double 
filling exchange. The choice of 30% PFO was made to avoid 
the formation of meniscus in the macular area and to mini-
mize the weight of the PFO bubble on the retina.
Improvements of ERG and bf ERG after removal of the 
double fill tamponade supported its retinal tolerability and 
demonstrated recovery of the retinal tissues from the surgical 
procedure. Because ERG is an expression of electrical func-
tion of the entire retinal tissue and not only of the macula, 
it is not possible to statistically correlate visual acuity and 
ERG parameters.
Even if double filling is potentially toxic, when removed 
within 3 weeks, any retinal surface toxicity is temporary, 
as indicated by the improvement of electrophysiological 
parameters after its removal. Postoperative IOP increased 
in 30% of our patients and in every case was successfully 
treated with topical therapy. Further proliferation had a low 
incidence (10%) and electroretinography did not demonstrate 
retinal damage.
Regarding the anatomic results, the Silicon Study 
Report 1122 showed at 36 months an anatomic success in 
86% of cases treated with silicon oil for retina detachment 
complicated by severe PVR with BCVA $ 10/50 in 24% 
of cases.
A recent retrospective study on 33 eyes treated with 
heavy silicon oil for complicated retinal detachment reported 
an anatomic success rate of 87.9% with first surgery with 
BCVA.23 In our series, the primary success rate, without 
further procedures, was 80% with an improvement of BCVA 
in 46.7% of the cases.
This study indicates that short-term double filling with 
30% PFO and 70% PDMS can be considered effective 
Table 5 Electroretinogram (full-field) resultsa
Mean at 2 weeks after double filling removal 
(standard deviation)
55.6 (24.7)
Mean at 8 weeks after double filling removal 
(standard deviation)
61.6 (26.0)
95% confidence interval for means difference 
of a correlated sample with paired data 
(tα/2 at 19 degrees of freedom is equal to 2.093)
1.02;10.86
Note: aThe interval excludes the 0 so that the difference of means is statistically 
significant.
Table 6 Bright flash electroretinogram resultsa
Mean at 2 weeks after double filling removal 
(standard deviation)
107.2 mV (49.7)
Mean at 8 weeks after double filling removal 
(standard deviation)
128.9 mV (65.8)
95% confidence interval for means difference 
of a correlated sample with paired data 
(tα/2 at 19 degrees of freedom is equal to 2.093)
4.43;38.98
Note: aThe interval excludes the 0 so that the difference of means is statistically 
significant.Clinical Ophthalmology
Publish your work in this journal
Submit your manuscript here: http://www.dovepress.com/clinical-ophthalmology-journal
Clinical Ophthalmology is an international, peer-reviewed journal 
covering all subspecialties within ophthalmology. Key topics include: 
Optometry; Visual science; Pharmacology and drug therapy in eye 
diseases; Basic Sciences; Primary and Secondary eye care; Patient 
Safety and Quality of Care Improvements. This journal is indexed on 
PubMed Central and CAS, and is the official journal of The Society of 
Clinical Ophthalmology (SCO). The manuscript management system 
is completely online and includes a very quick and fair peer-review 
system, which is all easy to use. Visit http://www.dovepress.com/ 
testimonials.php to read real quotes from published authors.





Ocular tolerance and efficacy of short-term tamponade
with no permanent functional retinal toxicity. The main 
  limitations of our study were the low number of patients and 
the inherent limitations of ERG in detecting other types of 
retinal   damages. Further studies are necessary to compare 
the   ocular tolerance and advantages of temporary endotam-
ponade double filling with other tamponades in the treatment 
of complicated RRD.
Disclosure
The authors report no conflicts of interest in this work.
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